APMONIA THERAPEUTICS
Apmonia Therapeutics developing a pipeline of next generation peptide based therapies targeting the tumor microenvironment to improve the lives of patients with cancer. If anyone would want to contact them please contact them via phone call or email.
APMONIA THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Reims, Champagne-Ardenne, France
Country:
France
Website Url:
http://www.apmonia-therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+33 3 26 91 89 84
Email Addresses:
[email protected]
Total Funding:
5.2 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API WordPress Google Maps Font Awesome Sitelinks Search Box Yoast WordPress SEO Plugin Person Schema
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
VIVAN Therapeutics
VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Probionova
Probionova is a research company that develops and provides probiotic strains and premixes for pharmaceuticals and nutraceuticals.
Current Advisors List
Current Employees Featured
Founder
Investors List
France 2030
France 2030 investment in Grant - Apmonia Therapeutics
Bpifrance
Bpifrance investment in Venture Round - Apmonia Therapeutics
Official Site Inspections
http://www.apmonia-therapeutics.com Semrush global rank: 14.22 M Semrush visits lastest month: 59
- Host name: cluster027.hosting.ovh.net
- IP address: 54.36.91.62
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Apmonia Therapeutics"
About us - Apmonia therapeutics
Apmonia Therapeutics was founded in 2019 as spin-off of CNRS and Reims university (UMR 7369 MEDyC). Executive team now gathers together members with decades of experience in …See details»
Apmonia Therapeutics - Crunchbase Company Profile …
When was the last funding round for Apmonia Therapeutics? Apmonia Therapeutics closed its last funding round on Jul 15, 2024 from a Venture - …See details»
Apmonia Therapeutics 2025 Company Profile: …
Apmonia Therapeutics has raised $7.24M. Who are Apmonia Therapeutics’s investors? European Innovation Council Fund , Bpifrance , Angels Santé , …See details»
Apmonia Therapeutics - Funding, Financials, Valuation & Investors
Apmonia Therapeutics is a biotech company that develops therapeutic strategies for cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Apmonia Therapeutics - Company Profile - Tracxn
Mar 12, 2025 Apmonia Therapeutics. has raised a total funding of $7.62M over 4 rounds. Its first funding round was on Feb 11, 2022. What are the most recent funding rounds of Apmonia …See details»
Apmonia Therapeutics - VentureRadar
Apmonia Therapeutics is a biotechnology company based in Reims (France) dedicated to the development of anti-cancer therapies. Building on renowned expertise in oncology as well as …See details»
APMONIA THERAPEUTICS - Societe.com
APMONIA THERAPEUTICS, société par actions simplifiée, au capital social de 24191,30 EURO, dont le siège social est situé au 2 RUE LEON PATOUX, 51100 REIMS, immatriculée au …See details»
Apmonia Therapeutics - Contacts, Employees, Board Members
Organization. Apmonia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
Apmonia Therapeutics - HealthTech Innovation Days
Apmonia Therapeutics is a biotechnology company dedicated to developing therapeutic strategies towards cancer. We are developing a first-in-class pipeline of next-generation peptide-based …See details»
Pipeline - Apmonia therapeutics
Pipeline AP-01 Apmonia Therapeutics’ lead program is a peptide-based technology, named AP-01 or TAX2, targeting tumor-overexpressed thrombospondin-1 (TSP-1) in order to prevent …See details»
Apmonia Therapeutics announces a new licensing agreement with …
Sep 13, 2023 Exclusive license agreement for potential first-in-class candidate reinforces Apmonia Therapeutics' position as a leader in the development of therapies targeting the …See details»
Grant - Apmonia Therapeutics - 2024-07-15 - Crunchbase
Jul 15, 2024 Organization Name . Apmonia Therapeutics . Announced Date Jul 15, 2024; Funding Type Grant; Money Raised . obfuscated. obfuscated. Lead Investors. ... Apmonia …See details»
Apmonia Therapeutics - SATT NORD
Thématique : Pharmacie – Bio-industrie Applications : Développement Thérapeutique Partenariats et récompenses : Septembre 2022 : Apmonia therapeutics obtient un …See details»
Apmonia Therapeutics - Products, Competitors, Financials, …
La start-up rémoise Apmonia Therapeutics renforce sa collaboration avec l’Institut des biomolécules Max Mousseron. Dec 17, 2024. Publié le 1 min de lecture Albin Jeanne est le …See details»
Newsroom - Apmonia therapeutics
Apr 23, 2024 Apmonia Therapeutics to receive €2.5m grant and €7m equity investment from the European Innovation Council (EIC) as a laureate of the EIC Accelerator program. This major …See details»
Le rémois Apmonia Therapeutics lève des fonds pour déployer ses ...
Jul 25, 2024 La biotech rémoise Apmonia Therapeutics (15 salariés) est en cours de levée de fonds. L’objectif est de lever près de vingt millions d’euros, pour soutenir le développement …See details»
Apmonia Therapeutics - Updates, News, Events, Signals & Triggers
Apmonia Therapeutics is a biotech company that develops therapeutic strategies for cancer.See details»
Apmonia Therapeutics annonce une levée de fonds de 2,7 millions …
Apr 26, 2024 Apmonia Therapeutics fait partie des lauréats de la 11e édition du Concours d’Innovation i-Nov (organisé par Bpifrance) et recevra le montant le plus élevé de financement …See details»
Science & technology - Apmonia therapeutics
Apmonia Therapeutics’ peptide-based technology named AP-01 (or TAX2 peptide) acts as an orthosteric selective antagonist for thrombospondin-1 (TSP-1) binding to CD47 membrane …See details»